ESR1 and triple-negative breast carcinoma: BRACHYURY mRNA level expression in breast carcinomas with negativity for ER and/or PR is statistically significantly higher than those with positivity for ER and/or PR (9, 61), and triple-negative breast cancer (TNBC) is significantly higher than triple-positive and non-TNBC (61).